NASDAQ · PGNY
Healthcare · Medical - Healthcare Information Services
$27.55
Up+$1.64 (+6.33%)
Updated Oct 8, 2026, 7:00 AM
SID Score
6.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · PGNY
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
PGNY closed at $27.55 after 21 trading sessions, up 1.59% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $25.81 | $28.32 | $25.81 | $27.55 | 2.26M |
| Oct 6, 2026 | $25.86 | $26.24 | $25.56 | $25.91 | 868.32K |
| Oct 5, 2026 | $25.25 | $25.92 | $25.01 | $25.86 | 1.05M |
| Oct 2, 2026 | $24.96 | $25.455 | $24.87 | $25.23 | 939.65K |
| Oct 1, 2026 | $25.11 | $25.37 | $24.79 | $24.85 | 1.59M |
| Sep 30, 2026 | $24.83 | $25.49 | $24.80 | $25.19 | 980.45K |
| Sep 29, 2026 | $25.25 | $25.34 | $24.33 | $24.79 | 1.55M |
| Sep 28, 2026 | $25.47 | $25.96 | $25.40 | $25.52 | 1.08M |
| Sep 25, 2026 | $25.88 | $26.0475 | $25.3892 | $25.44 | 1.11M |
| Sep 24, 2026 | $25.66 | $26.21 | $25.25 | $25.97 | 1.33M |
| Sep 23, 2026 | $26.10 | $26.42 | $25.64 | $25.83 | 1.35M |
| Sep 22, 2026 | $26.96 | $27.15 | $26.155 | $26.24 | 882K |
| Sep 21, 2026 | $27.22 | $27.25 | $26.67 | $26.86 | 821.05K |
| Sep 18, 2026 | $27.01 | $27.30 | $26.95 | $27.13 | 3.14M |
| Sep 17, 2026 | $27.38 | $27.65 | $26.965 | $27.01 | 828.71K |
| Sep 16, 2026 | $27.63 | $27.92 | $27.145 | $27.38 | 864.47K |
| Sep 15, 2026 | $27.88 | $27.91 | $27.58 | $27.76 | 690.8K |
| Sep 14, 2026 | $27.69 | $27.98 | $27.42 | $27.85 | 1.06M |
| Sep 11, 2026 | $27.45 | $27.7699 | $27.315 | $27.35 | 1.24M |
| Sep 10, 2026 | $26.94 | $27.60 | $26.94 | $27.08 | 894.61K |
| Sep 9, 2026 | $26.74 | $27.22 | $26.475 | $27.12 | 1.12M |
The latest Smart Investors Daily articles mentioning PGNY.
Company
Market Activity
Research & News
PGNY research
Company profile and research snapshot.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 30, 2026 | Wells Fargo | Overweight | — |
| Sep 8, 2026 | Citizens | Market Outperform | — |
| Aug 21, 2026 | JP Morgan | Neutral | — |
| Aug 20, 2026 | Wells Fargo | Overweight | — |
| Aug 13, 2026 | Truist Securities | Buy | — |
No generated briefing is available yet.
ChartMill · Sep 21, 2026
Progyny (PGNY) passes quality growth filters with high ROIC, no debt, strong cash flow, and a 7/10 fundamental rating—worth a spot on quality investors' watchlists.
Yahoo · Sep 18, 2026
PGNY vs. CRL: Which Stock Is the Better Value Option?
Yahoo · Sep 18, 2026
Progyny has delivered a mixed ride for shareholders, with the stock climbing over the past year but still showing a steep decline over five years. This puts a sharper spotlight on what investors are really paying for its earnings today. With that backdrop, the key issue is whether the current share price around US$27 fairly reflects the company’s profit engine. Over the past 5 years, Progyny’s share price has fallen 57.5%, which raises the question of whether the market is reassessing how...
SeekingAlpha · Sep 17, 2026
Progyny (PGNY) remains a top fertility benefits leader with strong growth, margin expansion, and catalysts aheadâexplore the outlook and decide if itâs a...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PGNY.
